Trial participants reported more frequent side effects, such as nausea, vomiting, and gastrointestinal discomfort, with some experiencing more adverse events
Only the chemically modified levo-3,4-dihydroxy-phenylalanine (levodopa
Semaglutide, marketed under the brand names Wegovy (for weight loss) and Ozempic (for type 2 diabetes), currently accounts for 25 per cent of the total Rs 1,579 crore GLP-1 agonist market in India and a potential label expansion gives the company room to tap a new market, insulated from generics and Eli Lillys Mounjaro (tirzepatide), which swept the category last year in both value and volume share
Starting Thursday, a US review panel convened by the Food and Drug Administration is to consider whether seven of these peptides should be recommended for compounding -- when pharmacists or outsourcing facilities create custom drugs -- as interest in them surges
One without the other is a compromised system